LungFit™ GO is a portable inhaled nitric oxide treatment that was tested for treatment of nontuberculous mycobacteria (NTM), a difficult-to-treat bacteria that infects the lungs of people with CF. Nitric oxide is a gas molecule produced by the body that plays a key role in the immune system. Nitric oxide has been shown to kill bacteria and break down their biofilms -- protective layers formed by bacteria that make them more difficult to eliminate. Researchers believe that increasing levels of nitric oxide in the body could help eliminate bacteria and increase lung function in people with CF. 

Status

A pilot study to evaluate the safety and effectiveness of LungFit™ GO was completed. No further development in CF is planned at this time.

Sponsor

This program was sponsored by Beyond Air and partially funded by the Cystic Fibrosis Foundation.